Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort

Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort / Torti, C.; Lapadula, G.; Casari, S.; Puoti, M.; Nelson, M.; QUIROS ROLDAN, E.; Bella, D.; Pastore, G.; Ladisa, N.; Minoli, L.; Sotgiu, Giovanni; Mazzotta, F.; LO CAPUTO, S.; DI PERRI, G.; Filice, G.; Carosi, G.; Tinelli, C.. - In: BMC INFECTIOUS DISEASES. - ISSN 1471-2334. - 5:(2005). [10.1186/1471-2334-5-58]